DRIO - DarioHealth Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,461
7,394
5,170
2,803
823
Cost of Revenue
5,481
5,629
3,859
3,364
1,678
Gross Profit
1,980
1,765
1,311
-561
-855
Operating Expenses
Research Development
3,779
3,676
3,297
2,154
2,565
Selling General and Administrative
16,651
15,777
12,433
8,117
4,278
Total Operating Expenses
20,430
19,453
15,730
10,271
6,843
Operating Income or Loss
-18,450
-17,688
-14,419
-10,832
-7,698
Interest Expense
-
18
171
20
22
Total Other Income/Expenses Net
-
-97
-1,153
-35
578
Income Before Tax
-18,546
-17,803
-15,743
-10,887
-7,142
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-18,546
-17,803
-15,743
-10,887
-7,142
Net Income
-18,546
-17,803
-15,743
-10,887
-7,142
Net Income available to common shareholders
-18,546
-18,296
-15,998
-10,887
-7,296
Reported EPS
Basic
-
-0.78
-1.64
-2.09
-3.78
Diluted
-
-0.78
-1.64
-2.09
-3.78
Weighted average shares outstanding
Basic
-
23,413
9,628
5,203
1,898
Diluted
-
23,413
9,628
5,203
1,898
EBITDA
-
-17,578
-15,377
-10,480
-6,785